Clinical trials
Completed Crohn Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
317 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 4 |
| 2002 | 15 |
| 2003 | 8 |
| 2004 | 15 |
| 2005 | 16 |
| 2006 | 15 |
| 2007 | 15 |
| 2008 | 12 |
| 2009 | 8 |
| 2010 | 13 |
| 2011 | 23 |
| 2012 | 17 |
| 2013 | 9 |
| 2014 | 13 |
| 2015 | 17 |
| 2016 | 17 |
| 2017 | 24 |
| 2018 | 17 |
| 2019 | 18 |
| 2020 | 5 |
| 2021 | 16 |
| 2022 | 7 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 317 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 14 |
| Mayo Clinic | 12 |
| Abbott | 10 |
| AbbVie | 9 |
| Children's Hospital Medical Center, Cincinnati | 9 |
| Janssen Research & Development, LLC | 8 |
| Pfizer | 8 |
| University of Pennsylvania | 7 |
| Biogen | 6 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Crohn Disease | 317 |
| Colitis, Ulcerative | 100 |
| Inflammatory Bowel Diseases | 99 |
| Arthritis, Rheumatoid | 13 |
| Colitis | 8 |
| Diverticulitis | 8 |
| Inflammation | 8 |
| Arthritis, Psoriatic | 7 |
| Celiac Disease | 7 |
| Colonic Neoplasms | 6 |
Trials
Showing 1 to 25 of 317. Each trial links to its page on Pharma Observatory.
217 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.